Key Benefits:

Ability - AAC's cardiologists are all Board Certified (or Eligible) in Cardiovascular Disease with significant years of experience. This is in addition to Board Certification in Internal Medicine.

Affability - AAC's cardiologists answer your questions honestly and directly, while being sensitive to your specific needs.

Availability - Cardiologists are available 24-hours per day, 7 days a week to respond to urgent and emergent consultations. For your convenience, same day visits for urgent problems can be scheduled by call 435-2789 (or outside the 518 area code call toll-free 888-463-2001).

Capabilities:

Non-Invasive Services - In addition to providing comprehensive office visits and consultations, AAC provides a full-range of ambulatory diagnostic testing including EKG's, holter monitoring, exercise stress testing, cardiopulmonary exercise stress testing, event detection, transthoracic echocardiograms, carotids, transesophageal echocardiograms (hospital only), nuclear imaging (including myocardial perfusion, stress testing, pharmacological stress testing, and ventricular function studies), pacemaker and AICD checks, non-invasive cardiac output monitoring, chest x-rays, and a full CLIA-certified clinical laboratory.

Invasive & Interventional Services - AAC performs diagnostic heart catheterizations at St. Peter's Hospital, Albany Medical Center Hospital, and Glens Falls Hospital. In addition, AAC performs balloon PTCA, intracoronary stenting, and rotational atherectomy interventional services as well.

Clinical Research Programs - AAC is actively engaged in nearly several clinical research protocols at all times. The protocols currently underway include prospectively assessing patients with: Congestive Heart Failure including Squibb CV137-018, PRAISE II, Cohere Registry (Innovex) and YM087 (Parke-Davis); Lipid Disorders including Atorvastatin (Parke-Davis), Niaspan (KOS); Hypertension including CONVINCE (Searle); Coronary Artery Disease including PEACE (NIH), LIFE (Merck), WIZARD (Pfizer); and hospital-based studies including Valiant (Norvartis), Bravo (Smith Kline Beecham), Presto (Smith Kline Beecham), MADIT II (St. Peter's), Procardia v. Bayer (Bayer), and Redux II (Wyeth Ayerst).

Center for Preventive Medicine & Cardiovascular Health - AAC has developed a focused risk factor modification program call CardioFit for persons at risk for the development of coronary artery disease (CAD). This integrated program is designed to address all factors associated with CAD development.